|
|
Line 520: |
Line 520: |
|
| |
|
|
| |
|
| ==Downs Syndrome== <!--T:114--> | | ==Down's Syndrome== <!--T:114--> |
|
| |
|
|
| |
|
Line 530: |
Line 530: |
| *Seidl R, Tiefenthaler M, Hauser E, Lubec G. Effects of transdermal nicotine on cognitive performance in Down's syndrome. Lancet. 2000 Oct 21;356(9239):1409-10. doi: 10.1016/S0140-6736(00)02848-8. PMID: 11052587. | | *Seidl R, Tiefenthaler M, Hauser E, Lubec G. Effects of transdermal nicotine on cognitive performance in Down's syndrome. Lancet. 2000 Oct 21;356(9239):1409-10. doi: 10.1016/S0140-6736(00)02848-8. PMID: 11052587. |
| *Acknowledgements: We thank Pharmacia-Upjohn, Uppsala, Sweden, for providing transdermal nicotine patches. This study was supported by the Red Bull Company, Salzburg. | | *Acknowledgements: We thank Pharmacia-Upjohn, Uppsala, Sweden, for providing transdermal nicotine patches. This study was supported by the Red Bull Company, Salzburg. |
| | | <br> |
| | |
| | |
|
| |
|
| ==Endurance / Exercise / Athletic Performance== <!--T:117--> | | ==Endurance / Exercise / Athletic Performance== <!--T:117--> |